This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.90% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-growth: Archive
Is It Worth Investing in Itron (ITRI) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Itron (ITRI) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ITRIPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Consolidated Water (CWCO) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Consolidated Water (CWCO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CWCOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
AudioEye (AEYE) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for AudioEye (AEYE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
AEYEPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Core & Main (CNM) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Core & Main (CNM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CNMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Analog Devices (ADI): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Analog Devices (ADI) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ADIPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Brinker International (EAT) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Brinker International (EAT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
EATNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Johnson & Johnson (JNJ) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Johnson & Johnson (JNJ) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
JNJNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Brinker International (EAT) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Brinker International (EAT) could produce exceptional returns because of its solid growth attributes.
EATNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
RMDPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook Carpenter (CRS)
by Zacks Equity Research
Carpenter (CRS) could produce exceptional returns because of its solid growth attributes.
CRSPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Wall Street Analysts Think Teradyne (TER) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Teradyne (TER) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
TERPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Teekay Tankers (TNK): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Teekay Tankers (TNK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
TNKPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Archrock Inc. (AROC): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Archrock Inc. (AROC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
AROCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Cipher Mining (CIFR) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Cipher Mining (CIFR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CIFRPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is PPL (PPL) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for PPL (PPL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
PPLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Datadog (DDOG) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Datadog (DDOG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
DDOGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Commvault (CVLT) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Commvault (CVLT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CVLTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
MCKPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About VALE (VALE): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in VALE (VALE). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
VALEPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Dell Technologies (DELL) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Dell Technologies (DELL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
DELLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Equinox Gold (EQX) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Equinox Gold (EQX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
EQXPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
New Gold (NGD) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
New Gold (NGD) could produce exceptional returns because of its solid growth attributes.
NGDPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Growth Investors Will Love Agnico (AEM)
by Zacks Equity Research
Agnico (AEM) possesses solid growth attributes, which could help it handily outperform the market.
AEMPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Brokers Suggest Investing in GE (GE): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in GE (GE). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
GEPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Monday.com (MNDY) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Monday.com (MNDY). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
MNDYNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth